about
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Pericyte dynamics during angiogenesis: new insights from new identitiesReversal of axonal growth defects in an extraocular fibrosis model by engineering the kinesin-microtubule interface.The cytoskeleton and neurite initiationβIII-Tubulin: biomarker of taxane resistance or drug target?Neurosensory Differentiation and Innervation Patterning in the Human Fetal Vestibular End Organs between the Gestational Weeks 8-12.Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotectiveIgG autoantibody to brain beta tubulin III associated with cytokine cluster-II discriminate cerebral malaria in central India.Dynamic 3D culture promotes spontaneous embryonic stem cell differentiation in vitro.Tubulin proteomics: towards breaking the code.Characterization of the colchicine binding site on avian tubulin isotype betaVI.Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells.Developmental corneal innervation: interactions between nerves and specialized apical corneal epithelial cells.A novel xenogeneic co-culture system to examine neuronal differentiation capability of various adult human stem cells.StearoylCoA desaturase-5: a novel regulator of neuronal cell proliferation and differentiation.The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activitiesHallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformation.Stem-like cells in bone sarcomas: implications for tumorigenesis.Tropomyosin-4 correlates with higher SBR grades and tubular differentiation in infiltrating ductal breast carcinomas: an immunohistochemical and proteomics-based study.Optimising parameters for the differentiation of SH-SY5Y cells to study cell adhesion and cell migrationFHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).Identification of a novel FRMD7 splice variant and functional analysis of two FRMD7 transcripts during human NT2 cell differentiation.Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology.Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer CellsCross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials.Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion.Transcriptomic Analysis of Induced Pluripotent Stem Cells Derived from Patients with Bipolar Disorder from an Old Order Amish Pedigree.Role of gamma-synuclein in microtubule regulation.Flip channel: A microfluidic device for uniform-sized embryoid body formation and differentiation.Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinomaOptimizing neuronal differentiation of human pluripotent NT2 stem cells in monolayer cultures.Nerve fibers in breast cancer tissues indicate aggressive tumor progressionMolecular Analysis of Stromal Cells-Induced Neural Differentiation of Mouse Embryonic Stem Cells.Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cellsComparative proteomic analysis of paclitaxel resistance-related proteins in human breast cancer cell lines.Increased levels of a unique post-translationally modified betaIVb-tubulin isotype in liver cancerClass III beta-tubulin is a component of the mitotic spindle in multiple cell types.A label-free mass spectrometry method for the quantification of protein isotypes.Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P.Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.
P2860
Q26781365-C149775D-54AA-4C45-9027-48B8D883814DQ27008071-3AC62CC6-530A-4D3A-A5BB-300364D8B33AQ27342394-E8B24FD5-1792-41B4-826D-A569A46E7A70Q27687036-9D42CF4C-D101-4FA6-8784-2313410A7C71Q28284878-34E710F1-2DFA-4E44-AB93-8BFA32AEBE59Q30369088-171478B3-D454-49F1-A4DA-28C17790E3C1Q30539763-AAA92965-9241-4BC4-85C8-5B4897A993F3Q33518569-65266365-5F3F-470C-B84E-442A3A9A18FAQ33644333-5490FBC4-6DAD-4948-806B-428EE81AB7D1Q33687990-DCC217AB-6DB5-475D-B9EA-4A9056F5C990Q33780549-9D1EF04E-7FE9-42F1-8312-C25E23BC3F93Q33780697-92E2FF7D-3702-4376-B2A1-4CED725853EAQ33845428-570CD92B-3CAC-47D6-BA2F-C75E66C47F17Q34026370-DCD9358D-B32D-480B-8270-611528E889B2Q34321675-D3361D2B-127C-4611-BE49-AB8DA5E3663AQ34525286-D2B1A8A6-56FC-46FF-BCC1-550885BEBE12Q34719865-4CD1303A-FB45-414A-8DC9-A9E0D9B035ABQ34769927-00783F89-9D40-4F9E-A2DD-8428421A4330Q34787142-600440BA-8415-4850-9465-FF9F413B545BQ34985083-6EC9319D-117D-4E81-A48E-4284E8340557Q35103393-1FDF0168-0B3E-44DE-9585-4B258A2E1CC0Q35575049-DD5A24AC-5507-433B-B207-8041FDA5B1F5Q35634946-4884E1F7-BB00-44D3-BDEA-92F5BF84DFC8Q35656185-8B67434A-1398-48DF-A4C6-2A27EB46DEF6Q35747285-284F15AE-FEE2-4165-A6F6-29984482474EQ35769314-6D5AD974-CD96-473E-BFA6-BD3606090211Q35837073-983B20A0-A48B-45A3-BE51-CB31347799B8Q35885349-45482A73-537B-4AB5-9F13-7654304A27B0Q36117865-775CA3DD-8784-44A7-A9A2-16B75936AD8BQ36130919-1D4825C9-F7B8-451C-A6AA-C82BA62F8480Q36145552-58FB45E4-6AD8-4877-9D4A-4FD208977214Q36152614-CA764FFE-8C5F-4F5C-95F2-FC30BFFA7397Q36188760-0FBF89D3-2B2E-4309-8C1B-EC0283EBADF7Q36206248-24A04E58-85E9-4A9E-B050-E56349CA5C6DQ36260567-40DBFD99-3862-49FF-858E-F589A106D8ADQ36952750-21146CC4-90C8-47A9-8059-6355AECEC7EAQ36974926-FDF681C3-01E5-4637-B615-FB44AA50E94CQ37013235-B498481C-12CE-47C2-8B21-8CE78F7F2854Q37278360-90592BF4-FB3A-4CC3-BB40-F0A275A885A7Q37376411-4844D36F-6269-488A-8EB3-D5B8222F2E30
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Class III beta-tubulin in human development and cancer.
@ast
Class III beta-tubulin in human development and cancer.
@en
type
label
Class III beta-tubulin in human development and cancer.
@ast
Class III beta-tubulin in human development and cancer.
@en
prefLabel
Class III beta-tubulin in human development and cancer.
@ast
Class III beta-tubulin in human development and cancer.
@en
P2093
P2860
P356
P1433
P1476
Class III beta-tubulin in human development and cancer.
@en
P2093
Christos D Katsetos
Mary M Herman
Sverre J Mörk
P2860
P356
10.1002/CM.10116
P577
2003-06-01T00:00:00Z